Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Thibault

Showing results (81-90 of 124) with videos related to

Pageof 13
Sort By:
Journal of Hepatology|July 23, 2003
Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis BRobert P Myers, Marie Hélène Tainturier, Vlad Ratziu, et al.
Arthritis and Rheumatism|November 6, 2004
Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infectionLaurent Vallat, Yves Benhamou, Maya Gutierrez, et al.
AIDS (London, England)|August 9, 2013
Efficacy and tolerance of telaprevir in HIV-hepatitis C virus genotype 1-coinfected patients failing previous antihepatitis C virus therapy: 24-week resultsKarine Lacombe, Nadia Valin, Hind Stitou, et al.
Nephron. Physiology|March 25, 2006
Changing electrolyte and acido-basic profile in HIV-infected patients in the HAART eraCorinne Isnard Bagnis, Sophie Tezenas Du Montcel, Michele Fonfrede, et al.
Fertility and Sterility|September 8, 2009
HIV-1 or hepatitis C chronic infection in serodiscordant infertile couples has no impact on infertility treatment outcomeNadia Prisant, Roland Tubiana, Gilles Lefebvre, et al.
Journal of Hepatology|November 9, 2005
Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1Yves Benhamou, Vincent Thibault, Pamela Vig, et al.
Clinics and Research in Hepatology and Gastroenterology|March 1, 2011
HCV-GenoFibrotest: a combination of viral, liver and genomic (IL28b, ITPA, UGT1A1) biomarkers for predicting treatment response in patients with chronic hepatitis CJean-Marc Costa, Dmytro Telehin, Mona Munteanu, et al.
Journal of Clinical Microbiology|February 8, 2005
Comparison of hepatitis C virus NS5b and 5' noncoding gene sequencing methods in a multicenter studySyria Laperche, Françoise Lunel, Jacques Izopet, et al.
Journal of Hepatology|July 13, 2014
Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®)Thierry Poynard, Julien Vergniol, Yen Ngo, et al.
ESC Heart Failure|May 2, 2021
Successful heart transplantation for COVID-19-associated post-infectious fulminant myocarditisBaptiste Gaudriot, Alexandre Mansour, Vincent Thibault, et al.
Pageof 13

Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
Journal of Hepatology|July 23, 2003
Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis BRobert P Myers, Marie Hélène Tainturier, Vlad Ratziu, et al.
Arthritis and Rheumatism|November 6, 2004
Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infectionLaurent Vallat, Yves Benhamou, Maya Gutierrez, et al.
AIDS (London, England)|August 9, 2013
Efficacy and tolerance of telaprevir in HIV-hepatitis C virus genotype 1-coinfected patients failing previous antihepatitis C virus therapy: 24-week resultsKarine Lacombe, Nadia Valin, Hind Stitou, et al.
Nephron. Physiology|March 25, 2006
Changing electrolyte and acido-basic profile in HIV-infected patients in the HAART eraCorinne Isnard Bagnis, Sophie Tezenas Du Montcel, Michele Fonfrede, et al.
Fertility and Sterility|September 8, 2009
HIV-1 or hepatitis C chronic infection in serodiscordant infertile couples has no impact on infertility treatment outcomeNadia Prisant, Roland Tubiana, Gilles Lefebvre, et al.
Journal of Hepatology|November 9, 2005
Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1Yves Benhamou, Vincent Thibault, Pamela Vig, et al.
Clinics and Research in Hepatology and Gastroenterology|March 1, 2011
HCV-GenoFibrotest: a combination of viral, liver and genomic (IL28b, ITPA, UGT1A1) biomarkers for predicting treatment response in patients with chronic hepatitis CJean-Marc Costa, Dmytro Telehin, Mona Munteanu, et al.
Journal of Clinical Microbiology|February 8, 2005
Comparison of hepatitis C virus NS5b and 5' noncoding gene sequencing methods in a multicenter studySyria Laperche, Françoise Lunel, Jacques Izopet, et al.
Journal of Hepatology|July 13, 2014
Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®)Thierry Poynard, Julien Vergniol, Yen Ngo, et al.
ESC Heart Failure|May 2, 2021
Successful heart transplantation for COVID-19-associated post-infectious fulminant myocarditisBaptiste Gaudriot, Alexandre Mansour, Vincent Thibault, et al.
Pageof 13